BBI
IBB icon

Baxter Bros Inc’s iShares Biotechnology ETF IBB Stock Holding History

Baxter Bros Inc’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$941K Buy
4,949
+1,137
+30% +$195K 0.11% 95
2026
Q1 		$644K Buy
3,812
+1,200
+46% +$205K 0.08% 107
2025
Q4 		$441K Buy
2,612
+240
+10% +$39K 0.05% 121
2025
Q3 		$342K Buy
+2,372
New +$324K 0.04% 128
2025
Q2 		– Sell
-1,989
Closed -$254K – 155
2025
Q1 		$254K Buy
1,989
+373
+23% +$50.6K 0.03% 138
2024
Q4 		$214K Sell
1,616
-756
-32% -$106K 0.03% 152
2024
Q3 		$345K Sell
2,372
-552
-19% -$79.9K 0.04% 127
2024
Q2 		$401K Sell
2,924
-681
-19% -$90.9K 0.05% 119
2024
Q1 		$495K Buy
3,605
+593
+20% +$81K 0.06% 108
2023
Q4 		$409K Buy
3,012
+1,183
+65% +$144K 0.06% 113
2023
Q3 		$224K Buy
+1,829
New +$233K 0.03% 137

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Baxter Bros Inc's IBB Position: Q2 2026 in Review

Baxter Bros Inc increased its iShares Biotechnology ETF (IBB) stake by 30% in Q2 2026, buying an estimated $195K and bringing the position to 4,949 shares worth $941K. The position accounts for 0.11% of the portfolio, ranked #95.

Baxter Bros Inc first reported a position in IBB in Q3 2023 and has held it in 11 quarters since. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Baxter Bros Inc held 4,949 shares of iShares Biotechnology ETF worth $941K as of Q2 2026.
  • Baxter Bros Inc bought 1,137 iShares Biotechnology ETF shares in Q2 2026, an estimated $195K.
  • iShares Biotechnology ETF made up 0.11% of Baxter Bros Inc's portfolio in Q2 2026, its #95 holding.
  • Baxter Bros Inc first reported a position in iShares Biotechnology ETF in Q3 2023 and has held it in 11 quarters since.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Baxter Bros Inc's 13F filing for Q2 2026, filed 6 Aug 2026.